Assessment of Preclinical Target Organ Damage in Hypertension

Assessment of Preclinical Target Organ Damage in Hypertension

 In the natural history of hypertension, the compensatory increase in left ventricular mass ceases to be beneficial. Left ventricular hypertrophy (LVH) becomes a preclinical disease and an independent risk factor for congestive heart failure, ischemic heart disease, arrhythmia, sudden death, and stroke. In addition to elevated BP, several mechanisms are involved, including body size, age, gender, race, fibrogenic cytokines, and neurohumoral factors, notably angiotensin II, which favor interstitial collagen deposition and perivascular fibrosis. These tissue changes are responsible for the insidious contractile dysfunction that is associated with LVH, consequent to decreased coronary reserve and altered diastolic ventricular filling and relaxation. The cardinal investigations are echocardiography and electrocardiography. All antihypertensive drugs regress LVH, notably those that act on the renin-angiotensin-aldosterone system, which also could target the detrimental tissue changes. Regression enhances systolic midwall performance, normalizes autonomic function, and restores coronary reserve.

    Related Conference of Assessment of Preclinical Target Organ Damage in Hypertension

    December 26-27, 2024

    28th World Cardiology Conference

    Paris, France
    February 20-21, 2025

    35th International Conference on Cardiology and Healthcare

    Amsterdam, Netherlands
    February 20-21, 2025

    14th World Congress on Cardiology

    Amsterdam, Netherlands
    February 24-25, 2025

    40th World Cardiology Conference

    London, UK
    February 27-28, 2025

    4th Global Summit on Cardiology and Cardiac Surgery

    Paris, France
    March 24-25, 2025

    14th World Heart Congress

    Paris, France
    April 16-17, 2025

    8th World Heart and Brain Conference

    Tokyo, Japan
    April 24-25, 2025

    9th Annual Heart Rhythm Conference

    Vienna, Austria
    April 28-29, 2025

    37th World Congress on Cardiology & Heart Diseases

    Frankfurt, Germany
    April 28-29, 2025

    39th World Congress on Heart Diseases

    Frankfurt, Germany
    May 19-20, 2025

    4th International Conference on Cardiology

    Rome, Italy
    May 22-23, 2025

    5th World Congress on Congestive Heart Failure & Angina

    Zurich, Switzerland
    May 26-27, 2025

    6th European Summit on Cardiology Research

    Rome, Italy
    August 11-12, 2025

    3rd International Conference on World Heart Care

    Toronto, Canada
    August 21-22, 2025

    8th Global Cardiovascular Research and Clinical Cardiology

    Vancouver, Canada
    September 08-09, 2025

    39th European Cardiology Conference

    Frankfurt, Germany
    September 22-23, 2025

    7th Annual Conference on Vascular Medicine

    Amsterdam, Netherlands

    Assessment of Preclinical Target Organ Damage in Hypertension Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in